Unboxing IQOS: History, risk perceptions, and clinical implications

Duration:

60 Minutes

Webinar Speakers

Pamela M. Ling, MD, MPH

Professor of Medicine in the Division of General Internal Medicine and Director of the Center for Tobacco Control Research and Education, University of California, San Francisco

Pam Ling is a Professor of Medicine in the Division of General Internal Medicine and Director of the Center for Tobacco Control Research and Education. Her research is on tobacco, media, and social marketing with an emphasis on young people. She focuses on understanding how tobacco marketing encourages youth and young adults to initiate tobacco use, and counter-engineering these strategies to improve tobacco control programs. She conducts research on marketing of smokeless tobacco products and other new and alternative tobacco products, including electronic cigarettes. The goal of this work is to use market research strategies to improve clinical, policy, and public health interventions. She also directs the Postdoctoral Research Fellowship Training Program and sees patients as a primary care provider.

Minji Kim, PhD

Postdoctoral Fellow, Center for Tobacco Control Research and Education (CTCRE), University of California, San Francisco

Minji Kim is a postdoctoral fellow at Center for Tobacco Control Research and Education (CTCRE), University of California, San Francisco. Kim's research focuses on targeted and tailored health communication. Kim's recent project include examining targeted marketing and counter-marketing of emerging tobacco products, and how that impacts vulnerable populations. First, she is actively engaging in tobacco control policy by making public comments and publishing on novel tobacco product marketing, such as e-cigarettes and heated tobacco products, including IQOS (Philip Morris International). Second, Kim is working with under-served Asian American community to develop culturally appropriate anti-tobacco intervention. She is also is examining the effects of psychographic targeting strategy, such as using peer groups that share values and social identity, in tobacco marketing and counter-marketing messages for youth and young adults. Kim received a Ph.D. in Communication from the Annenberg School for Communication, University of Pennsylvania. Prior to her academic life, she worked as an associate consultant at The Boston Consulting Group’s Seoul office.

Webinar Objectives
  1. Compare the features and marketing claims of current and past heated tobacco products, included the "IQOS" product recently introduced in the US
  2. Identify three features of IQOS product, packaging or promotional claims that influence young adult tobacco users' perceptions of IQOS risk and benefits
  3. Synthesize the available data on product features, marketing and health in clinical recommendations for discussing IQOS and other heated tobacco product use in clinical settings
Instructions for CME/CEU Credit

CME/CEU registration has closed for this live activity. The recorded version of the webinar will be available for credit by September.

 

Certificates of Attendance

 

Click here to generate a certificate of attendance for participating on this webinar.

 

ACCME Accreditation

The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the webinar activity.

Advance Practice Registered Nurses and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.

Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 CreditTM are acceptable for continuing medical education requirements for recertification.

California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 CreditTM. If you are a pharmacist in another state, you should check with your state board for approval of this credit.

California Psychologists: The California Board of Psychology recognizes and accepts for continuing education credit courses that are provided by entities approved by the Accreditation Council for Continuing Medical Education (ACCME). AMA PRA Category 1 CreditTM is acceptable to meeting the CE requirements for the California Board of Psychology. Providers in other states should check with their state boards for acceptance of CME credit.

California Behavioral Science Professionals: University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for behavioral health providers. UCSF maintains responsibility for this program/course and its content.

Course meets the qualifications for 1.0 hour of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences. Provider # 64239.

ACCREDITATION FOR CALIFORNIA ADDICTION COUNSELORS

The UCSF office of continuing medical education is accredited by the California Consortium of Addiction Programs and Professionals (CCAPP), to provide continuing education credit for California addiction counselors. UCSF designates this live, virtual activity, for a maximum of 1.0 CCAPP credit. Addiction counselors should claim only the credit commensurate with the extent of their participation in the activity. Provider number: 7-20-322-0722.

Disclosures

This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

The following speakers, moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:

Anita Browning, Christine Cheng, Brian Clark, Minji Kim, PhD, Pamela Ling, MD, MPH, Jennifer Matekuare, Ma Krisanta Pamatmat, MPH, Jessica Safier, MA, Catherine Saucedo, Steven A. Schroeder, MD, and Aria Yow, MA.